CONTOUR® NEXT GEN Blood Glucose Monitoring System
Brand(s)
Last updated
Summary
Product
CONTOUR® NEXT GEN Blood Glucose Monitoring System
Issue
Medical devices - Performance
What to do
Contact the manufacturer if you require additional information.
Affected products
| Affected products | Lot or serial number | Model or catalog number |
|---|---|---|
| CONTOUR® NEXT GEN Blood Glucose Monitoring System | PH25010004 | 7923 |
| CONTOUR® NEXT GEN Blood Glucose Monitoring System | PH24110008 | 7923 |
| CONTOUR® NEXT GEN Blood Glucose Monitoring System | PH25010003 | 7923 |
| CONTOUR® NEXT GEN Blood Glucose Monitoring System | PH24110007 | 7923 |
| CONTOUR® NEXT GEN Blood Glucose Monitoring System | PH24110009 | 7923 |
Issue
This recall pertains to 33 CONTOUR® NEXT GEN Blood Glucose Monitoring Systems (glucose meters) identified as displaying blood glucose readings in incorrect units of measure (i.e. mg/dl instead of mmol/l), which may result in misinterpretation of glucose levels. The affected devices were distributed between 2025-02-25 to 2025-04-21.
Recall start date: June 23, 2025
Additional information
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Medical devices - Chemistry
Companies
Ascensia Diabetes Care Holdings AG
Peter Merian-Strasse 90, Basel, Switzerland, 4052
Published by
Health Canada
Audience
General public
Healthcare
Recall class
Type II
Identification number
RA-77671
Get notified
Receive notifications for new and updated recalls and alerts by category.